FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ann-Lii Cheng

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Sung-Hsin Kuo; Wen-Hui Weng; Kun-Huei Yeh; Li-Tzong Chen; Ann-Lii Cheng
No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply.
Hideki Ueno; Taketo Yamaguchi; Kenji Yamao; Hiroaki Yanagimoto; Hideo Baba; Narikazu Boku; Jen-Shi Chen; Ann-Lii Cheng; Shinichi Egawa; Akira Fukutomi; Akihiro Funakoshi; Junji Furuse; Takashi Hatori; Masafumi Ikeda; Tatsuya Ioka; Masayuki Kitano; Kazuhiro Mizumoto; Yasuo Ohashi; Shinichi Ohkawa; Takuji Okusaka; Atsushi Sato; Tomotaka Shimamura; Masayuki Sho; Kazuya Sugimori; Masao Tanaka
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study.
Yu-Chieh Tsai; Tsung-Fan Tuan; Kai-Yuan Tzen; Chih-Hsien Yeh; Ann-Lii Cheng; Pei-Yin Ho; Yeong-Shiau Pu; Jason Chia-Hsien Cheng
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ann-Lii Cheng (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sung-Hsin Kuo; Wen-Hui Weng; Kun-Huei Yeh; Li-Tzong Chen; Ann-Lii Cheng
No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply.
Genes, chromosomes & cancer 2013;52(6):593-4.
2013: Hideki Ueno; Taketo Yamaguchi; Kenji Yamao; Hiroaki Yanagimoto; Hideo Baba; Narikazu Boku; Jen-Shi Chen; Ann-Lii Cheng; Shinichi Egawa; Akira Fukutomi; Akihiro Funakoshi; Junji Furuse; Takashi Hatori; Masafumi Ikeda; Tatsuya Ioka; Masayuki Kitano; Kazuhiro Mizumoto; Yasuo Ohashi; Shinichi Ohkawa; Takuji Okusaka; Atsushi Sato; Tomotaka Shimamura; Masayuki Sho; Kazuya Sugimori; Masao Tanaka
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(13):1640-8.
2013: Yu-Chieh Tsai; Tsung-Fan Tuan; Kai-Yuan Tzen; Chih-Hsien Yeh; Ann-Lii Cheng; Pei-Yin Ho; Yeong-Shiau Pu; Jason Chia-Hsien Cheng
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma.
European journal of cancer (Oxford, England : 1990) 2013;49(6):1458-66.
2013: Li-Chun Lu; Yi-Yuan Shao; Wen-Yi Shau; Yi-Chun Yeh; Ann-Lii Cheng; Chih-Hung Hsu; Raymond N C Kuo; Zhong-Zhe Lin; Mei-Shu Lai
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.
Cancer 2013;119(6):1210-6.
2013: Joong-Won Park; Ronnie T Poon; Chee-Kiat Tan; Tawesak Tanwandee; Gaojun Teng; Deepak Amarapurkar; Yee Chao; Pei-Jer Chen; Jean-Francois H Geschwind; Khean-Lee Goh; Kwang-Hyub Han; Masatoshi Kudo; Han Chu Lee; Rheun-Chuan Lee; Laurentius A Lesmana; Ho Yeong Lim; Seung Woon Paik; Ann-Lii Cheng
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).
Liver international : official journal of the International Association for the Study of the Liver 2013;33(3):327-37.
2013: Ching-Hung Lin; Jacqueline M Liu; Yen-Shen Lu; Chung-Chieh Wang; Chiun-Sheng Huang; Kuan-Ting Kuo; Chieh Lan; Wei-Chung Lee; Dwan-Ying Chang; Ann-Lii Cheng
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
Journal of clinical pathology 2013;66(2):140-5.
2013: Hui-Chuan Yu; Ya-Ling Chang; Hui-Ju Chen; Ann-Lii Cheng; Chun-Yu Liu; Chung-Wai Shiau; Kuen-Feng Chen
Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma.
Biochemical pharmacology 2013;85(3):356-66.
2013: Kuen-Feng Chen; Pei-Jer Chen; Hui-Ling Chen; Pei-Yi Chu; Kimihisa Ichikawa; Chun-Yu Liu; Chung-Wai Shiau; Wei-Tien Tai; Ann-Lii Cheng
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody.
British journal of pharmacology 2013;168(3):658-72.
2013: Y-C Shen; C-Y Chang; Chiun Hsu; C-Y Lin; K-L Lin; S-H Liu; D-L Ou; Ann-Lii Cheng
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.
British journal of cancer 2013;108(1):72-81.
2013: Hui-Chuan Yu; Ann-Lii Cheng; Duen-Ren Hou; Chen-Si Lin; Chun-Yu Liu; Chung-Wai Shiau; Kuen-Feng Chen
Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome.
PloS one 2013;8(2):e55705.
2012: Yi-Yuan Shao; Y-C Shen; Chiun Hsu; Chih-Hung Hsu; Z-Z Lin; L-C Lu; Ann-Lii Cheng
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.
British journal of cancer 2012;107(10):1672-7.
2012: Yu-Yun Shao; Hui-Ching Tu; Chi-Long Chen; Ming-Chih Ho; Chih-Hung Hsu; Chien-Chung Huang; Ann-Lii Cheng
Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma.
Anticancer research 2012;32(11):4865-70.
2012: Geoffrey Ku; Sudsawat Laohavinij; Iain Beehuat Tan; Thomas Yau; Narikazu Boku; Ann-Lii Cheng; Yoon-Koo Kang; GILBERTO LOPES
Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.
The lancet oncology 2012;13(11):e470-81.
2012: Kuo-Hsing Chen; Yueh-Hung Chou; Ann-Lii Cheng
Primary squamous cell carcinoma of the thyroid with cardiac metastases and right ventricle outflow tract obstruction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):e260-3.
2012: Li-Chun Lu; Yu-Yun Shao; Ann-Lii Cheng; Wen-Fang Cheng; Chiun Hsu; Chih-Hung Hsu; Yu-Lin Lin; Kun-Huei Yeh
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer.
Anticancer research 2012;32(8):3397-401.
2012: Kuen-Feng Chen; Pei-Jer Chen; Jing-Ping Lin; Chun-Yu Liu; Chung-Wai Shiau; Wei-Tien Tai; Hui-Chuan Yu; Ann-Lii Cheng
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.
Biochemical pharmacology 2012;84(3):268-77.
2012: Sung-Hsin Kuo; Chun-Wei Wang; Yu-Hsuan Chen; Ann-Lii Cheng; Chia-Hung Chou; Ruey-Jien Chen
Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
Gynecologic oncology 2012;126(2):245-51.
2012: Seok Jin Kim; Won Seog Kim; Jae Yong Kwak; Ann-Lii Cheng; Yu Yan Hwang; Tanin Intragumtornchai; Surapol Issaragrisil; Hawk Kim; Jin Seok Kim; Je-Jung Lee; Soon Thye Lim; Joon Ho Moon; Arry Harryanto Reksodiputro; Jong Ho Won; Yok-Lam Kwong
Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group.
Leukemia & lymphoma 2012;53(8):1515-24.
2012: Yu-Yun Shao; Chih-Hung Hsu; Chien-Chung Huang; Shiou-Der Lin; Ann-Lii Cheng
Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(14):3992-7.
2012: Yu-Chin Lin; Ann-Lii Cheng; Ching-Chow Chen; Kuei-Chiu Chen; Kuen-Feng Chen
CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells.
Oral oncology 2012;48(7):585-93.
2012: Ann-Lii Cheng; Fang Fang; Zhongzhen Guan; Zhendong Chen; Jun Suk Kim; Giuseppe Lentini; Hongming Pan; Shukui Qin; Won Young Tak; Chao-Jung Tsao; Dimitris Voliotis; Jianming Xu; Tsai-Sheng Yang; Shiying Yu; Jessie Zou; Yoon-Koo Kang
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial.
European journal of cancer (Oxford, England : 1990) 2012;48(10):1452-65.
2012: Yu-Chin Lin; Tzu-Tang Wei; Meng-Hsuan Wu; Shu-Hui Chuang; Kuen-Feng Chen; Ann-Lii Cheng; Ching-Chow Chen
Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.
Neoplasia (New York, N.Y.) 2012;14(6):463-75.
2012: Yen-Shen Lu; Kai-Yuan Tzen; Ann-Lii Cheng; Chia-Hung Chou; Ming Gao; Samuel K Kulp; Jason Chia-Hsien Cheng
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma.
International journal of radiation oncology, biology, physics 2012;83(2):e181-9.
2012: Ching-Hung Lin; Yen-Shen Lu; San-Lin You; Yong-Chen Chen; Wen-Fang Cheng; Chun-Ju Chiang; Chiun-Sheng Huang; Kuan-Ting Kuo; Mei-Shu Lai; Ann-Lii Cheng
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country.
International journal of cancer. Journal international du cancer 2012;130(11):2629-37.
2012: Sung-Hsin Kuo; Chung-Wu Lin; Hsiu-Po Wang; Ming-Shiang Wu; Kun-Huei Yeh; Li-Tzong Chen; Ping-Ning Hsu; Ann-Lii Cheng
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.
Blood 2012;119(21):4838-44; quiz 5057.
2012: Chiun Hsu; Wen-Tsung Huang; Teh-Ia Huo; Wei-Shou Hwang; Robin Meng; Tsai-Sheng Yang; Chih-Wei Yu; Yee Chao; Ruey-Kuen Hsieh; Tsai-Yuan Hsieh; Ann-Lii Cheng
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.
Journal of hepatology 2012;56(5):1097-103.
2012: Chao-Yuan Huang; Chia-Cheng Wei; Hui-Ju Chen; Kuei-Chiu Chen; Ann-Lii Cheng; Kuen-Feng Chen
Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A.
Cancer letters 2012;317(1):9-15.
2012: Kuen-Feng Chen; Pei-Jer Chen; Kimihisa Ichikawa; Chun-Yu Liu; Wei-Tien Tai; Hui-Ling Chen; Ann-Lii Cheng
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
Biochemical pharmacology 2012;83(6):769-77.
2012: Wen-Hong Kuo; Ching-Hung Lin; Po-Han Lin; Tsang-Pai Liu; Yen-Shen Lu; Aaron M Sargeant; Ann-Lii Cheng; Yin-Hsiu Chien; Fon-Jou Hsieh; Ai-Chu Huang; Wuh-Liang Hwu; Li-Yuan Bai; King-Jen Chang
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer.
Journal of human genetics 2012;57(2):130-8.
2012: Wei-Tien Tai; Pei-Jer Chen; Ann-Lii Cheng; Ching-Huai Ko; Mai-Wei Lin; Chun-Yu Liu; Chung-Wai Shiau; Kuen-Feng Chen
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.
Molecular cancer therapeutics 2012;11(2):452-63.
2012: Yu-Hsuan Kuo; Ching-Hung Lin; Yen-Shen Lu; Wen-Yi Shau; Shih-Hung Yang; Te-Jung Chen; Chun Hsu; Shu-Min Huang; Ann-Lii Cheng
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy.
BMC cancer 2012;12():620.
2012: Yu-Lin Lin; Da-Liang Ou; Li-Hui Tseng; Kun-Huei Yeh; Shan-Chi Yu; Yih-Leong Chang; Jau-Yu Liau; Liang-In Lin; Ann-Lii Cheng
KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells.
PloS one 2012;7(11):e50701.
2012: Shin-Yi Jou; Ching-Hwa Tsai; Chun-Hsien Wu; Chien-Chih Chang; Mei-Ru Chen; Yun-Hui Chen; Ann-Lii Cheng; Wen-Hui Chuang; Shin-Lian Doong
BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage.
Journal of biomedical science 2012;19():85.
2012: Zhong-Zhe Lin; Yu-Yun Shao; Chih-Hsin Yang; Dwan-Ying Chang; Ruey-Long Hong; Chiun Hsu; Chih-Hung Hsu; Fu-Chang Hu; Ann-Lii Cheng
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.
The oncologist 2012;17(7):970-7.
2012: Wen-Yi Shau; Yi-Chun Yeh; Zhong-Zhe Lin; Yu-Yun Shao; Ann-Lii Cheng; Chiun Hsu; Chih-Hung Hsu; Raymond Kuo; Mei-Shu Lai
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.
The oncologist 2012;17(6):856-62.
2012: Ying-Chun Shen; Chia-Chi Cheng; Chiun Hsu; Fu-Chang Hu; Ann-Lii Cheng
A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression.
Oncology 2012;82(5):275-89.
2012: Wei-Wu Chen; Ann-Lii Cheng; Raymond N C Kuo; Zhong-Zhe Lin; Yen-Shen Lu; Yu-Yun Shao; Wen-Yi Shau; Ho-Min Chen; Mei-Shu Lai
The impact of diabetes mellitus on prognosis of early breast cancer in Asia.
The oncologist 2012;17(4):485-91.
2012: Yu-Yun Shao; Yin-Chun Shen; Chi-Huang Hsiao; Chiun Hsu; Chih-Hung Hsu; Chien-Chung Huang; Kuan-Der Lee; Zhong-Zhe Lin; Yen-Shen Lu; Ann-Lii Cheng
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma.
Oncology 2012;82(1):59-66.
2012: Chia-Hung Yen; Chia-Yen Chen; Kuen-Feng Chen; Ann-Lii Cheng; Ming-Yuan Cheng; Shiu-Feng Huang; Cheng-Ming Lee; Yan-Hwa Wu Lee; Chung-Hsien Li; Li-Ying Liao; Yao-Cheng Lu; Yi-Ming Arthur Chen
Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma.
Molecular medicine (Cambridge, Mass.) 2012;18():286-96.
2011: Sung-Hsin Kuo; Chung-Wu Lin; Yi-Shin Tzeng; Ming-Shiang Wu; Kun-Huei Yeh; Ann-Lii Cheng; Chih-Hung Hsu; Li-Tzong Chen
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
Cancer chemotherapy and pharmacology 2011;68(6):1387-95.
2011: Hui-Ju Ch'ang; Jang-Yang Chang; Ming-Chu Chang; Jen-Shi Chen; Ann-Lii Cheng; Yen-Feng Chiu; Ruey-Kuen Hsieh; Chih-Hung Hsu; Tsann-Long Hwang; Pin-Wen Lin; Yu-Lin Lin; Yan-Shen Shan; Yu-Wen Tien; Hsiu-Po Wang; Jacqueline Whang-Peng; Li-Tzong Chen
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study.
International journal of radiation oncology, biology, physics 2011;81(5):e749-57.
2011: Yu-Yun Shao; Pei-Jer Chen; Yea-Hui Ding; Chih-Hung Hsu; Chien-Chung Huang; Ying-Hui Lee; Zhong-Zhe Lin; Ann-Lii Cheng
Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma.
Anticancer research 2011;31(11):4007-11.
2011: Sung-Hsin Kuo; Chung-Wu Lin; Hui-Jen Tsai; Wen-Hui Weng; Ming-Shiang Wu; Kun-Huei Yeh; Li-Tzong Chen; Zi-Hua Chen; Ping-Ning Hsu; Huei-Jiuan Jeng; Ann-Lii Cheng
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma.
Genes, chromosomes & cancer 2011;50(11):908-21.
2011: Wei-Tien Tai; Pei-Jer Chen; Ann-Lii Cheng; Hsiang-Po Huang; Jui-Wen Huang; Chung-Wai Shiau; Kuen-Feng Chen
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.
Journal of hepatology 2011;55(5):1041-8.
2011: Chao-Yu Hsu; Fu-Chang Hu; Ying-Chun Shen; Bang-Bin Chen; Ann-Lii Cheng; Chiun Hsu; Chih-Hung Hsu; Shwu-Yuan Wei; Chih-Wei Yu; Tiffany Ting-Fang Shih
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
Journal of hepatology 2011;55(4):858-65.
2011: Ching-Hung Lin; Po-Han Lin; Yen-Shen Lu; Chung-Chieh Wang; San-Lin You; Dwan-Ying Chang; King-Jen Chang; Chiun-Sheng Huang; Kuan-Ting Kuo; Wen-Hung Kuo; Ann-Lii Cheng
Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?
Journal of clinical pathology 2011;64(9):781-7.
2011: Sandrine Faivre; Seock-Ah Im; Yoon-Koo Kang; Jun S Kim; Silvana Lanzalone; Maria J Lechuga; Ho Y Lim; Xun Lin; Mohamed Bouattour; Eveline Boucher; Ann-Lii Cheng; Safi Dokmak; Jean-Yves Douillard; Chantal Dreyer; Marie-Paule Sablin; Camille Serrate; Valérie Vilgrain; Magaly Zappa; Eric Raymond
Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4504-12.
2011: Kuen-Feng Chen; Pei-Jer Chen; Wei-Lin Chen; Ann-Lii Cheng; Cheng-Yi Hsu; Jui-Wen Huang; Wei-Tien Tai; Chung-Wai Shiau
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.
European journal of medicinal chemistry 2011;46(7):2845-51.
2011: Benjamin A T Rodriguez; Yu-I Weng; Ta-Ming Liu; Tao Zuo; Pei-Yin Hsu; Ching-Hung Lin; Ann-Lii Cheng; Hengmi Cui; Pearlly S Yan; Hui-Ming (Tim) Huang
Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.
Carcinogenesis 2011;32(6):812-21.
2011: Jen-Shi Chen; Yee Chao; Ruey-Kuen Hsieh; Ann-Lii Cheng; Po-Min Chen; Tzeon-Jye Chiou; Tsu-Yi Chao; Kun-Huei Yeh; Li-Tzong Chen; Jacqueline Whang-Peng
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.
Cancer chemotherapy and pharmacology 2011;67(6):1281-9.
2011: Kuen-Feng Chen; Hui-Chuan Yu; Chun-Yu Liu; Hui-Ju Chen; Yi-Ching Chen; Duen-Ren Hou; Pei-Jer Chen; Ann-Lii Cheng
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A.
Molecular cancer therapeutics 2011;10(5):892-901.
2011: Sung-Hsin Kuo; Chih-Hung Hsu; Li-Tzong Chen; Yen-Sen Lu; Ching-Huang Lin; Pei-Yen Yeh; Huei-Jiuan Jeng; Ming Gao; Kun-Huei Yeh; Ann-Lii Cheng
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001.
European journal of cancer (Oxford, England : 1990) 2011;47(8):1244-57.
2011: Kuen-Feng Chen; Hui-Ling Chen; Wei-Tien Tai; Wen-Chi Feng; Chih-Hung Hsu; Pei-Jer Chen; Ann-Lii Cheng
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells.
The Journal of pharmacology and experimental therapeutics 2011;337(1):155-61.
2011: Yunn-Fang Ho; Wan-Chen Lu; Russel Rhei-Long Chen; Ann-Lii Cheng; Kun-Huei Yeh
Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
Anti-cancer drugs 2011;22(3):290-8.
2011: John F P Bridges; Ann-Lii Cheng; Gisselle Gallego; Kwang-Hyub Han; Susan M Joy; Masatoshi Kudo; Sheng-Long Ye; Barri M Blauvelt
Needs for hepatocellular carcinoma control policy in the Asia-Pacific region.
Asian Pacific journal of cancer prevention : APJCP 2011;12(10):2585-91.
2011: Ann-Lii Cheng; Ying-Chun Shen; Andrew X Zhu
Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma.
Oncology 2011;81(5-6):372-80.
2011: Yu-Yun Shao; Ying-Chun Shen; Te-Jung Chen; Chiun Hsu; Chih-Hung Hsu; Zhong-Zhe Lin; Ann-Lii Cheng
High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.
Oncology 2011;81(2):98-103.
2011: Charles S Harmon; Jun S Kim; Silvana Lanzalone; Maria José Lechuga; Ho Y Lim; Xun Lin; Eric Raymond; Eveline Boucher; Ann-Lii Cheng; Samuel E DePrimo; Jean-Yves Douillard; Sandrine Faivre
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.
Journal of translational medicine 2011;9():120.
2011: Pei-Yen Yeh; Yen-Shen Lu; Da-Liang Ou; Ann-Lii Cheng
IκB kinases increase Myc protein stability and enhance progression of breast cancer cells.
Molecular cancer 2011;10():53.
2011: Yu-Lin Lin; Kun-Huei Yeh; Ann-Lii Cheng
Recent advances in the treatment of metastatic colorectal cancer in Taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhi 2011;110(1):1-3.
2011: Yu-Yun Shao; Li-Chun Lu; Ann-Lii Cheng; Chih-Hung Hsu
Increasing incidence of brain metastasis in patients with advanced hepatocellular carcinoma in the era of antiangiogenic targeted therapy.
The oncologist 2011;16(1):82-6.
2010: Chun-Te Chiang; Pei-Yen Yeh; Ming Gao; Chun-Wei Chen; Ling-Chun Yeh; Wen-Chi Feng; Sung-Hsin Kuo; Chih-Hung Hsu; Yen-Shen Lu; Ann-Lii Cheng
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma.
Cancer letters 2010;298(2):195-203.
2010: Kuen-Feng Chen; C-Y Liu; Y-C Lin; H-C Yu; T-H Liu; D-R Hou; Pei-Jer Chen; Ann-Lii Cheng
CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
Oncogene 2010;29(47):6257-66.
2010: Da-Liang Ou; Ying-Chun Shen; Sung-Liang Yu; Kuen-Feng Chen; Pei-Yen Yeh; Hsiang-Hsuan Fan; Wen-Chi Feng; Ching-Tzu Wang; Liang-In Lin; Chiun Hsu; Ann-Lii Cheng
Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells.
Cancer research 2010;70(22):9309-18.
2010: Kuen-Feng Chen; Wei-Tien Tai; Tsung-Hao Liu; Hsiang-Po Huang; Yu-Chin Lin; Chung-Wai Shiau; Pui-Kai Li; Pei-Jer Chen; Ann-Lii Cheng
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(21):5189-99.
2010: Ting-Yun Liu; Shee-Uan Chen; Sung-Hsin Kuo; Ann-Lii Cheng; Chung-Wu Lin
E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(11):1507-17.
2010: Yu-I Weng; Pei-Yin Hsu; Sandya Liyanarachchi; Joseph Liu; Daniel E Deatherage; Yi-Wen Huang; Tao Zuo; Benjamin Rodriguez; Ching-Hung Lin; Ann-Lii Cheng; Hui-Ming (Tim) Huang
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells.
Toxicology and applied pharmacology 2010;248(2):111-21.
2010: Yu-Yun Shao; Zhong-Zhe Lin; Chiun Hsu; Ying-Chun Shen; Chih-Hung Hsu; Ann-Lii Cheng
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
Cancer 2010;116(19):4590-6.
2010: Masatoshi Kudo; Kwang-Hyub Han; Norihiro Kokudo; Ann-Lii Cheng; Byung Ihn Choi; Junji Furuse; Namiki Izumi; Joong-Won Park; Ronnie T Poon; Michiie Sakamoto
Liver Cancer Working Group report.
Japanese journal of clinical oncology 2010;40 Suppl 1():i19-27.
2010: Ying-Chun Shen; Chiun Hsu; Ann-Lii Cheng
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives.
Journal of gastroenterology 2010;45(8):794-807.
2010: Wei-Cheng Lin; Hwei-Fang Tsai; Sung-Hsin Kuo; Ming-Shiang Wu; Chung-Wu Lin; Ping-I Hsu; Ann-Lii Cheng; Ping-Ning Hsu
Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma.
Cancer research 2010;70(14):5740-8.
2010: Po-Han Lin; Yen-Shen Lu; Ching-Hung Lin; Daw-Yuan Chang; Chiun-Shen Huang; Ann-Lii Cheng; Kun-Huei Yeh
Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.
Anticancer research 2010;30(7):3087-91.
2010: Chih-Hung Hsu; Ying-Chun Shen; Zhong-Zhe Lin; Pei-Jer Chen; Yu-Yun Shao; Yea-Hui Ding; Chiun Hsu; Ann-Lii Cheng
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
Journal of hepatology 2010;53(1):126-31.
2010: Ying-Chun Shen; Chiun Hsu; Li-Tzong Chen; Chia-Chi Cheng; Fu-Chang Hu; Ann-Lii Cheng
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach.
Journal of hepatology 2010;52(6):889-94.
2010: Pei-Fang Wu; Kuan-Ting Kuo; Lu-Ting Kuo; Yi-Ting Lin; Wei-Chung Lee; Yen-Shen Lu; Chih-Hsin Yang; Ruey-Meei Wu; Yong-Kwang Tu; Jui-Chang Tasi; Ham-Min Tseng; Sheng-Hong Tseng; Ann-Lii Cheng; Ching-Hung Lin
O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.
Lung cancer (Amsterdam, Netherlands) 2010;68(3):484-90.
2010: Yu-Yun Shao; Fu-Chang Hu; Jin-Tung Liang; Wen-Tzu Chiu; Ann-Lii Cheng; Chih-Hsin Yang
Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions.
Journal of the Formosan Medical Association = Taiwan yi zhi 2010;109(5):362-8.
2010: Yu-Yun Shao; Kuan-Ting Kuo; Fu-Chang Hu; Yen-Shen Lu; Chiun-Sheng Huang; Jau-Yu Liau; Wei-Chung Lee; Chiun Hsu; Wun-Hon Kuo; King-Jeng Chang; Ching-Hung Lin; Ann-Lii Cheng
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin.
Japanese journal of clinical oncology 2010;40(4):286-93.
2010: Sung-Hsin Kuo; Ruoh-Fang Yen; Chung-Wu Lin; Li-Tzong Chen; Hwei-Fang Tien; Ann-Lii Cheng
Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma.
Annals of hematology 2010;89(4):431-6.
2010: Chih-Hung Hsu; T-S Yang; Chiun Hsu; H C Toh; R J Epstein; L-T Hsiao; P-J Chen; Z-Z Lin; Tsu-Yi Chao; Ann-Lii Cheng
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.
British journal of cancer 2010;102(6):981-6.
2010: Kun-Huang Yan; Chih-Jung Yao; Hwan-You Chang; Gi-Ming Lai; Ann-Lii Cheng; Shuang-En Chuang
The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
Molecular carcinogenesis 2010;49(3):235-46.
2010: Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann-Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang-Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun-Fan Liaw; Shiv Kumar Sarin
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.
Hepatology international 2010;4(2):439-74.
2010: Zhong-Zhe Lin; Yung-Ming Jeng; Fu-Chang Hu; Hung-Wei Pan; HW Tsao; Po-Lin Lai; Po-Huang Lee; Ann-Lii Cheng; Hey-Chi Hsu
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
BMC cancer 2010;10():461.
2010: Ching-hung Lin; Huang-chun Lien; Fu-Chang Hu; Yen-shen Lu; Sung-hsin Kuo; Ling-chu Wu; San-Lin You; Ann-Lii Cheng; King-Jen Chang; Chiun-Sheng Huang
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy.
Journal of Zhejiang University. Science. B 2010;11(1):1-9.
2010: Kuen-Feng Chen; Hui-Chuan Yu; Tsung-Hao Liu; Shoei-Sheng Lee; Pei-Jer Chen; Ann-Lii Cheng
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
Journal of hepatology 2010;52(1):88-95.
2010: Chiun Hsu; Ying-Chun Shen; Chia-Chi Cheng; Fu-Chang Hu; Ann-Lii Cheng
Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design.
Contemporary clinical trials 2010;31(1):55-61.
2009: Chia Hung Chou; Pei-Jer Chen; Yung-Ming Jeng; Ann-Lii Cheng; Li-Rung Huang; Jason Chia-Hsien Cheng
Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway.
International journal of radiation oncology, biology, physics 2009;75(5):1545-52.
2009: Hui-Ju Ch'ang; Chin-Lun Huang; Hsiu-Po Wang; Her-Shyong Shiah; Ming-Chu Chang; Chang-Ming Jan; Jen-Shi Chen; Yu-Wen Tien; Tsann-Long Hwang; Jaw-Town Lin; Ann-Lii Cheng; Jacqueline Whang-Peng; Li-Tzong Chen
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.
Cancer chemotherapy and pharmacology 2009;64(6):1173-9.
2009: Chia-Chi Lin; Chih-Hung Hsu; Jason C Cheng; Chao-Yuan Huang; Yu-Chieh Tsai; Feng-Ming Hsu; Kuo-How Huang; Ann-Lii Cheng; Yeong-Shiau Pu
Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
International journal of radiation oncology, biology, physics 2009;75(2):442-8.
2009: Da-Liang Ou; Ying-Chun Shen; Ja-Der Liang; Jun-Yang Liou; Sung-Liang Yu; Hsiang-Hsuan Fan; Da-Sheng Wang; Yen-Shen Lu; Chiun Hsu; Ann-Lii Cheng
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5820-8.
2009: Chiun Hsu; Shu-Chen Wei; Ann-Lii Cheng; Pei-Jer Chen
Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy.
Hepatology (Baltimore, Md.) 2009;50(2):654-5.
2009: Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S Kim; Magaly Zappa; Silvana Lanzalone; Xun Lin; Samuel Deprimo; Charles Harmon; Ana Ruiz-Garcia; Maria J Lechuga; Ann-Lii Cheng
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study.
The lancet oncology 2009;10(8):794-800.
2009: Chiun Hsu; Ann-Lii Cheng; Pei-Jer Chen
Lamivudine and hepatitis B reactivation.
Annals of internal medicine 2009;151(2):141; author reply 141-2.
2009: Shih-Hung Yang; Zhong-Zhe Lin; Sung-Hsin Kuo; Ann-Lii Cheng
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma.
American journal of hematology 2009;84(7):457-9.
2009: Ching-Hung Lin; Jau-Yu Liau; Yen-Shen Lu; Chiun-Sheng Huang; Wei-Chung Lee; Kuan-Ting Kuo; Ying-Chun Shen; Sung-Hsin Kuo; Chieh Lan; Jacqueline Ming Liu; Wun-Hon Kuo; King-Jen Chang; Ann-Lii Cheng
Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(6):1807-14.
2009: Yu-Chin Lin; Chung-Hsin Tsai; Jia-Shing Wu; Chiun-Sheng Huang; Sung-Hsin Kuo; Chung-Wu Lin; Ann-Lii Cheng
Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients.
Leukemia & lymphoma 2009;50(6):918-24.
2009: Chien-Hung Chen; Fu-Chang Hu; Guan-Tarn Huang; Po-Huang Lee; Yuk-Ming Tsang; Ann-Lii Cheng; Ding-Shinn Chen; Jung-Der Wang; Jin-Chuan Sheu
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patients.
European journal of cancer (Oxford, England : 1990) 2009;45(9):1630-9.
2009: Chin-Lun Huang; Chih-Hsin Yang; Kun-Huei Yeh; Fu-Chang Hu; Kuan-Yu Chen; Jin-Yuan Shih; Zhong-Zhe Lin; Chong-Jen Yu; Ann-Lii Cheng; Pan-Chyr Yang
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment.
Lung cancer (Amsterdam, Netherlands) 2009;64(3):346-51.
2009: Yu-Yun Shao; Zhong-Zhe Lin; Po-Chin Liang; Yu-Wen Tien; Ann-Lii Cheng
Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment.
Anticancer research 2009;29(5):1665-7.
2009: Kuen-Feng Chen; Pei-Yen Yeh; Chiun Hsu; Chih-Hung Hsu; Yen-Shen Lu; Hsing-Pang Hsieh; Pei-Jer Chen; Ann-Lii Cheng
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
The Journal of biological chemistry 2009;284(17):11121-33.
2009: J-H Lee; Ann-Lii Cheng; C-W Lin; S-H Kuo
Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.
The British journal of dermatology 2009;160(4):887-9.
2009: Zhong-Zhe Lin; Hey-Chi Hsu; Chih-Hung Hsu; Pei-Yen Yeh; Chi-Ying F Huang; Yung-Feng Huang; Te-Jung Chen; Sung-Hsin Kuo; Chiun Hsu; Fu-Chang Hu; Yung-Ming Jeng; Ying Chung; Ann-Lii Cheng
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.
Journal of hepatology 2009;50(3):518-27.
2009: Ying-Chun Shen; Fu-Chang Hu; Yung-Ming Jeng; Yu-Ting Chang; Zhong-Zhe Lin; Ming-Chu Chang; Chiun Hsu; Ann-Lii Cheng
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):417-23.
2009: Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk Kim; Rongcheng Luo; Jifeng Feng; Shenglong Ye; Tsai-Sheng Yang; Jianming Xu; Yan Sun; Houjie Liang; Jiwei Liu; Jiejun Wang; Won Young Tak; Hongming Pan; Karin Burock; Jessie Zou; Dimitris Voliotis; Zhongzhen Guan
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
The lancet oncology 2009;10(1):25-34.
2008: Sung-Hsin Kuo; Chiun-Sheng Huang; Wun-Hon Kuo; Ann-Lii Cheng; King-Jeng Chang; Jason Chia-Hsien Cheng
Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
International journal of radiation oncology, biology, physics 2008;72(5):1456-64.
2008: Chiun Hsu; Sow-Hsong Kuo; Fu-Chang Hu; Ann-Lii Cheng; Jin-Yuan Shih; Chong-Jen Yu; Chia-Chi Lin; Tsu-Chen Huang; Pan-Chyr Yang; Chih-Hsin Yang
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):334-43.
2008: Huei-Yue Dai; Chih-Chen Hong; San-Chi Liang; Ming-De Yan; Gi-Ming Lai; Ann-Lii Cheng; Shuang-En Chuang
Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway.
Molecular carcinogenesis 2008;47(12):956-63.
2008: Ming Gao; Pei-Yen Yeh; Yen-Shen Lu; Chih-Hung Hsu; Kuen-Feng Chen; Wei-Chung Lee; Wen-Chi Feng; Ching-Shih Chen; Min-Liang Kuo; Ann-Lii Cheng
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma.
Cancer research 2008;68(22):9348-57.
2008: Ming Gao; Pei-Yen Yeh; Yen-Shen Lu; WC Chang; Min-Liang Kuo; Ann-Lii Cheng
NF-kappaB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells.
Biochemical and biophysical research communications 2008;376(2):283-7.
2008: Chia-Chi Lin; Yeong-Shiau Pu; Chih-Hung Hsu; Hsiao-Yi Keng; Ann-Lii Cheng; Chih-Hsin Yang
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma.
Urologic oncology 2008;26(6):659-61.
2008: Sow-Hsong Kuo; Pei-Yen Yeh; Li-Tzong Chen; Ming-Shiang Wu; Chung-Wu Lin; Kun-Huei Yeh; Yi-Shin Tzeng; Jing-Yi Chen; Ping-Ning Hsu; Jaw-Town Lin; Ann-Lii Cheng
Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma.
Blood 2008;112(7):2927-34.
2008: Chih-Chen Hong; Jong-Ding Lay; Jhy-Shrian Huang; Ann-Lii Cheng; Jih-Luh Tang; Ming-Tseh Lin; Gi-Ming Lai; Shuang-En Chuang
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia.
Cancer letters 2008;268(2):314-24.
2008: Kuen-Feng Chen; Pei-Yen Yeh; Kun-Huei Yeh; Yen-Shen Lu; Shang-Yi Huang; Ann-Lii Cheng
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Cancer research 2008;68(16):6698-707.
2008: Chih-Hsin Yang; Chong-Jen Yu; Jin-Yuan Shih; Yeun-Chung Chang; Fu-Chang Hu; Meng-Chin Tsai; Kuan-Yu Chen; Zhong-Zhe Lin; Ching-Ju Huang; Chia-Tung Shun; Chin-Lun Huang; James Bean; Ann-Lii Cheng; William Pao; Pan-Chyr Yang
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2745-53.
2008: Zhong-Zhe Lin; Chiun Hsu; Yeun-Chung Chang; Chong-Jen Yu; Chih-Hung Hsu; Chia-Chi Lin; Ann-Lii Cheng; Pan-Chyr Yang; Chih-Hsin Yang
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):215-21.
2008: Ta-Chen Huang; Kun-Huei Yeh; Ann-Lii Cheng; Chih-Hung Hsu
Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation.
Anticancer research 2008;28(2B):1293-7.
2008: Chiun Hsu; Chao A Hsiung; Ih-Jen Su; Wei-Shou Hwang; Ming-Chung Wang; Sheng-Fung Lin; Tseng-Hsi Lin; Hui-Hua Hsiao; Ji-Hsiung Young; Ming-Chih Chang; Yu-Min Liao; Chi-Cheng Li; Hung-Bo Wu; Hwei-Fang Tien; Tsu-Yi Chao; Tsang-Wu Liu; Ann-Lii Cheng; Pei-Jer Chen
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
Hepatology (Baltimore, Md.) 2008;47(3):844-53.
2008: Jui-Hsiang Hung; Yen-Shen Lu; Yu-Chieh Wang; Yi-Hui Ma; Da-Sheng Wang; Samuel K Kulp; Natarajan Muthusamy; John C Byrd; Ann-Lii Cheng; Ching-Shih Chen
FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Cancer research 2008;68(4):1204-12.
2008: Huang-Chun Lien; Yen-Shen Lu; C-T Shun; Yu-Tung Yao; W-C Chang; Ann-Lii Cheng
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system.
Histopathology 2008;52(3):314-24.
2008: Sow-Hsong Kuo; Li-Tzong Chen; Ming-Shiang Wu; Chung-Wu Lin; Kun-Huei Yeh; Kuan-Ting Kuo; Pei-Yen Yeh; Yi-Shin Tzeng; Hsiu-Po Wang; Ping-Ning Hsu; Jaw-Town Lin; Ann-Lii Cheng
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment.
Annals of surgery 2008;247(2):265-9.
2007: Yen-Shen Lu; Yoko Kashida; Samuel K Kulp; Yu-Chieh Wang; Dasheng Wang; Jui-Hsiang Hung; Monica Tang; Zhong-Zhe Lin; Te-Jung Chen; Ann-Lii Cheng; Ching-Shih Chen
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2007;46(4):1119-30.
2007: Shang-Yi Huang; Ming Yao; Jih-Luh Tang; Wen-Chung Lee; Woei Tsay; Ann-Lii Cheng; Chiu-Hwa Wang; Yao-Chang Chen; Ming-Ching Shen; Hwei-Fang Tien
Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years.
Cancer 2007;110(4):896-905.
2007: Chia-Chi Lin; Kun-Huei Yeh; Chih-Hsin Yang; Chiun Hsu; Yu-Chieh Tsai; Wei-Ling Hsu; Ann-Lii Cheng; Chih-Hung Hsu
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.
Anti-cancer drugs 2007;18(6):703-8.
2007: Chia-Chi Lin; Chih-Hung Hsu; Tzyh-Chyuan Hour; Ann-Lii Cheng; Chao-Yuan Huang; Kuo-How Huang; Jun Chen; Yeong-Shiau Pu
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: in vitro combined effects and a phase II trial.
Urologic oncology 2007;25(3):207-13.
2007: Jong-Ding Lay; Chih-Chen Hong; Jhy-Shrian Huang; Ya-Yu Yang; Chung-Yi Pao; Ching-Hang Liu; Yi-Pin Lai; Gi-Ming Lai; Ann-Lii Cheng; Ih-Jen Su; Shuang-En Chuang
Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL.
Cancer research 2007;67(8):3878-87.
2007: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Hsiao-Yi Keng; Yu-Chieh Tsai; Kuo-How Huang; Ann-Lii Cheng; Yeong-Shiau Pu
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.
Anti-cancer drugs 2007;18(4):487-91.
2007: Yuh-Min Chen; Chong-Jen Yu; Chih-Hsin Yang; Reury-Perng Perng; Chun-Ming Tsai; Jen-Fu Shih; Ann-Lii Cheng; F Lefresne; M Barbier; J-C Pouget; Pan-Chyr Yang
A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2007;56(1):89-95.
2007: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Yu-Chieh Tsai; Kuo-How Huang; Ann-Lii Cheng; Yeong-Shiau Pu
Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
Urology 2007;69(3):479-84.
2007: Chia Hung Chou; Pei-Jer Chen; Po-Huang Lee; Ann-Lii Cheng; Hui-Chen Hsu; Jason Chia-Hsien Cheng
Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):851-7.
2007: Sow-Hsong Kuo; Li-Tzong Chen; Ming-Shiang Wu; Kuan-Ting Kuo; Kun-Huei Yeh; Shin-Lian Doong; Pei-Yen Yeh; Hey-Chi Hsu; Y-S Tzeng; Chung-Wu Lin; Jaw-Town Lin; Ann-Lii Cheng
Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
The Journal of pathology 2007;211(3):296-304.
2007: Chia-Chi Lin; Chiun Hsu; Chih-Hung Hsu; Wei-Ling Hsu; Ann-Lii Cheng; Chih-Hsin Yang
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
Investigational new drugs 2007;25(1):77-84.
2007: Yu-Lin Lin; Chih-Yuan Chung; Cheng-Shyong Chang; Jia-Shing Wu; Kuan-Ting Kuo; Sow-Hsong Kuo; Ann-Lii Cheng
Prognostic factors in extrapulmonary small cell carcinomas. A large retrospective study.
Oncology 2007;72(3-4):181-7.
2007: Chih-Hung Hsu; Ann-Lii Cheng
Clinical studies with curcumin.
Advances in experimental medicine and biology 2007;595():471-80.
2007: Chia-Chi Lin; Ann-Lii Cheng; Chih-Hung Hsu; Yen-Shen Lu; Chiun Hsu; Kun-Huei Yeh; Chen-Yao Wu; Chiun-Sheng Huang; Chih-Hsin Yang
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
Anticancer research 2007;27(1B):641-5.
2007: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Ann-Lii Cheng; Nicholas J Vogelzang; Yeong-Shiau Pu
Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
The Journal of urology 2007;177(1):84-9; discussion 89.
2006: Yi-Sun Yang; Mu-Zon Wu; Ann-Lii Cheng; Tien-Chun Chang
Primary thyroid lymphoma mimicking subacute thyroiditis.
Acta cytologica 2006;50(6):710-2.
2006: Yen-Shen Lu; Huang-Chun Lien; Pei-Yen Yeh; Sow-Hsong Kuo; Wen-Ching Chang; Min-Liang Kuo; Ann-Lii Cheng
Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity.
Lung cancer (Amsterdam, Netherlands) 2006;53(3):303-10.
2006: Tsu-Yao Cheng; Jaw-Town Lin; Li-Tzong Chen; Chia-Tung Shun; Hsiu-Po Wang; Ming-Tsang Lin; Tsang-En Wang; Ann-Lii Cheng; Ming-Shiang Wu
Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3483-9.
2006: Huang-Chun Lien; Yen-Shen Lu; Ann-Lii Cheng; W-C Chang; Yung-Ming Jeng; Y-H Kuo; Chiun-Sheng Huang; King-Jen Chang; Yu-Tung Yao
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms.
The Journal of pathology 2006;209(3):317-27.
2006: Hui-Ju Ch'ang; Chuan-Cheng Wang; Ann-Lii Cheng; Chiun Hsu; Yen-Shen Lu; Ming-Chu Chang; Jaw-Town Lin; Hsiu-Po Wang; Her-Shyong Shiah; Tsang-Wu Liu; Jang-Yang Chang; Jacqueline Whang-Peng; Li-Tzong Chen
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer.
Journal of gastroenterology and hepatology 2006;21(5):874-9.
2006: Chiun Hsu; Ying-Chun Shen; Chia-Chi Cheng; Ruey-Long Hong; Chee-Jen Chang; Ann-Lii Cheng
Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):856-61.
2006: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Ann-Lii Cheng; Jun Chen; Nicholas J Vogelzang; Yeong-Shiau Pu
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity.
Cancer 2006;106(6):1269-75.
2006: Her-Shyong Shiah; Ann-Lii Cheng; Chiun Hsu; Chih-Hung Hsu; Tsang-Wu Liu; Jang-Yang Chang; Chang-Ming Jan; Yee Chao; Wei-Lan Yu; Tsai-Rong Chuang; Jacqueline Whang-Peng; Li-Tzong Chen
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer.
Journal of gastroenterology and hepatology 2006;21(3):531-6.
2006: Ching-Hung Lin; Kuan-Ting Kuo; Shih-Sung Chuang; Sow-Hsong Kuo; Julia Hueimei Chang; Kung-Chao Chang; Hui-Chen Hsu; Hwei-Fang Tien; Ann-Lii Cheng
Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1152-6.
2006: Yen-Shen Lu; Pei-Yen Yeh; Shuang-En Chuang; Ming Gao; Min-Liang Kuo; Ann-Lii Cheng
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa.
The Journal of endocrinology 2006;188(2):311-9.
2006: Chih-Jung Yao; Gi-Ming Lai; Chin-Feng Chan; Ann-Lii Cheng; Ya-Yu Yang; Shuang-En Chuang
Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone.
International journal of cancer. Journal international du cancer 2006;118(3):773-9.
2006: Pei-Yen Yeh; Sow-Hsong Kuo; Kun-Huei Yeh; Shuang-En Chuang; Chih-Hung Hsu; Wen Ching Chang; Hsin-I Lin; Ming Gao; Ann-Lii Cheng
A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus.
The Journal of biological chemistry 2006;281(1):167-75.
2005: Yen-Shen Lu; Huang-Chun Lien; Pei-Yen Yeh; Kun-Huei Yeh; Min-Liang Kuo; Sow-Hsong Kuo; Ann-Lii Cheng
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
World journal of gastroenterology : WJG 2005;11(40):6373-80.
2005: Li-Tzong Chen; Jaw-Town Lin; John Jen Tai; Gran-Hum Chen; Hong-Zen Yeh; Sheng-Shun Yang; Hsiu-Po Wang; Sow-Hsong Kuo; Bor-Shyang Sheu; Chang-Ming Jan; Wen-Ming Wang; Tsang-En Wang; Cheng-Wen Wu; Chi-Long Chen; Ih-Jen Su; Jacqueline Whang-Peng; Ann-Lii Cheng
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Journal of the National Cancer Institute 2005;97(18):1345-53.
2005: Wen-Pin Su; Chi-Chung Wen; Chao A Hsiung; Ih-Jen Su; Ann-Lii Cheng; Ming-Chih Chang; Chao-Jung Tsao; Woei-Yau Kao; Wu-Ching Uen; Chiun Hsu; Chih-Hung Hsu; Yen-Shen Lu; Hwei-Fang Tien; Tsu-Yi Chao; Li-Tzong Chen; Jacqueline Whang-Peng; Pei-Jer Chen
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.
World journal of gastroenterology : WJG 2005;11(34):5283-8.
2005: Ying-Chun Shen; Chee-Jen Chang; Chiun Hsu; Chia-Chi Cheng; Chang-Fang Chiu; Ann-Lii Cheng
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(8):1986-90.
2005: Chih-Hsin Yang; Ching-Ju Huang; Chao-Shun Yang; Yu-Chuan Chu; Ann-Lii Cheng; Jacqueline Whang-Peng; Pan-Chyr Yang
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein.
Cancer research 2005;65(15):6943-9.
2005: Kun-Huei Yeh; Shiou-Hwei Yeh; Joeu-Pei Wan; Ying-Chun Shen; Ann-Lii Cheng
Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung.
Anti-cancer drugs 2005;16(7):739-42.
2005: Kun-Huei Yeh; Sow-Hsong Kuo; Li-Tzong Chen; Tsui-Lien Mao; Shin-Lian Doong; Ming-Shiang Wu; Hui-Chen Hsu; Yi-Shin Tzeng; Chi-Long Chen; Jaw-Town Lin; Ann-Lii Cheng
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21).
Blood 2005;106(3):1037-41.
2005: Sow-Hsong Kuo; Li-Tzong Chen; Chi-Long Chen; Shin-Lian Doong; Kun-Huei Yeh; Ming-Shiang Wu; Tsui-Lien Mao; Hui-Chen Hsu; Hsiu-Po Wang; Jaw-Town Lin; Ann-Lii Cheng
Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma.
World journal of gastroenterology : WJG 2005;11(28):4357-62.
2005: Ming-De Yan; Chih-Chen Hong; Gi-Ming Lai; Ann-Lii Cheng; Ya-Wen Lin; Shuang-En Chuang
Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas.
Human molecular genetics 2005;14(11):1465-74.
2005: Chiun Hsu; Chiung-Nien Chen; Li-Tzong Chen; Chen-Yao Wu; Fon-Jou Hsieh; Ann-Lii Cheng
Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors.
Radiology 2005;235(2):509-16.
2005: Sow-Hsong Kuo; Chih-Hsin Yang; Chong-Jen Yu; Chiun Hsu; Ann-Lii Cheng; Pan-Chyr Yang
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials.
Lung cancer (Amsterdam, Netherlands) 2005;48(2):275-80.
2005: Kun-Huei Yeh; Yen-Shen Lu; Chih-Hung Hsu; Jing-Fang Lin; H J Chao; T C Huang; C Y Chung; C S Chang; Chang-Hao Yang; Ann-Lii Cheng
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
British journal of cancer 2005;92(6):1013-8.
2005: Chun-Jung Lin; Mei-Hwan Wu; Yu-Mei Hsueh; Selma Siu-Man Sun; Ann-Lii Cheng
Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective.
Cancer chemotherapy and pharmacology 2005;55(2):170-8.
2005: Kun-Huei Yeh; Yen-Shen Lu; Chih-Hung Hsu; Jing-Fang Lin; Chiun Hsu; Sow-Hsong Kuo; Shiou-Jr Li; Ann-Lii Cheng
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
Oncology 2005;69(1):88-95.
2005: Chih-Hung Hsu; Ming Gao; Chi-Long Chen; Pei-Yen Yeh; Ann-Lii Cheng
Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro.
Oncology 2005;68(4-6):538-47.
2005: Chih-Hsin Yang; MIN-CHUN CHEN; Ann-Lii Cheng; Chih-Hung Hsu; Kun-Huei Yeh; Yu-Chie Yu; Jacqueline Whang-Peng; Pan-Chyr Yang
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatment.
Oncology 2005;68(4-6):350-5.
2004: Y-C Shen; Chiun Hsu; Jen-Yang Chen; Ann-Lii Cheng
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines.
British journal of cancer 2004;91(8):1561-5.
2004: Chih-Hung Hsu; Hui-Chen Hsu; Hui-Ling Chen; Ming Gao; Pei-Yen Yeh; Pei-Jer Chen; Ann-Lii Cheng
Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy.
Anticancer research 2004;24(5A):3035-40.
2004: Sow-Hsong Kuo; Li-Tzong Chen; Kun-Huei Yeh; Ming-Shiang Wu; Hui-Chen Hsu; Pei-Yen Yeh; Tsui-Lien Mao; Chi-Long Chen; Shin-Lian Doong; Jaw-Town Lin; Ann-Lii Cheng
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3491-7.
2004: Ming-Shiang Wu; Chia-Tung Shun; Shih-Pei Huang; Ann-Lii Cheng; Li-Tzong Chen; Jaw-Town Lin
Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma.
Haematologica 2004;89(8):1015-7.
2004: Ming-Shiang Wu; Li-Tzong Chen; Chia-Tung Shun; Shih-Pei Huang; Han-Mo Chiu; Hsiu-Po Wang; Ming-Tsang Lin; Ann-Lii Cheng; Jaw-Town Lin
Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma.
International journal of cancer. Journal international du cancer 2004;110(5):695-700.
2004: Chiun Hsu; Jason Chia-Hsien Cheng; Ann-Lii Cheng
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma.
Journal of the Formosan Medical Association = Taiwan yi zhi 2004;103(7):483-95.
2004: Yeong-Shiau Pu; Tzyh-Chyuan Hour; Shuang-En Chuang; Ann-Lii Cheng; Ming-Kuen Lai; Min-Liang Kuo
Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
The Prostate 2004;60(2):120-9.
2004: Pei-Yen Yeh; Kun-Huei Yeh; Shuang-En Chuang; Ying Chyi Song; Ann-Lii Cheng
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation.
The Journal of biological chemistry 2004;279(25):26143-8.
2004: Chiun Hsu; Y-C Shen; Chang-Hao Yang; Kun-Huei Yeh; Yen-Shen Lu; Chih-Hung Hsu; H-T Liu; Chi-Cheng Li; J-S Chen; Chen-Yao Wu; Ann-Lii Cheng
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
British journal of cancer 2004;90(9):1715-9.
2004: Yen-Shen Lu; Chiun Hsu; Chi-Cheng Li; Sow-Hsong Kuo; Kun-Huei Yeh; Chih-Hsin Yang; Chih-Hung Hsu; Chen-Yao Wu; Ann-Lii Cheng
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
Hepato-gastroenterology 2004;51(57):815-9.
2004: Pei-Yen Yeh; Shuang-En Chuang; Kun-Huei Yeh; Ying Chyi Song; Lucia Ling-Yuan Chang; Ann-Lii Cheng
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.
Oncogene 2004;23(20):3580-8.
2004: Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2645-51.
2004: Kun-Huei Yeh; Ann-Lii Cheng; Joeu-Pei Wan; Chien-Shing Lin; Chih-Chun Liu
Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells.
Anti-cancer drugs 2004;15(4):371-6.
2004: Kun-Huei Yeh; Ann-Lii Cheng
Recent advances in therapy for gastric cancer.
Journal of the Formosan Medical Association = Taiwan yi zhi 2004;103(3):171-85.
2003: Kun-Huei Yeh; Yen-Shen Lu; Chi-Huang Hsiao; Ann-Lii Cheng
High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma.
Anticancer research 2003;23(6D):5133-7.
2003: Wei-Liang Shih; Min-Liang Kuo; Shuang-En Chuang; Ann-Lii Cheng; Shin-Lian Doong
Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase.
The Journal of biological chemistry 2003;278(34):31807-13.
2003: Chiun Hsu; Jung-Der Wang; Jing-Shiang Hwang; Hwei-Fang Tien; Shueh-Mei Chang; Ann-Lii Cheng; Yao-Chang Chen; Jih-Luh Tang
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(5):503-17.
2003: Pei-Yen Yeh; Shuang-En Chuang; Kun-Huei Yeh; Ying Chyi Song; Ann-Lii Cheng
Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells.
Biochemical pharmacology 2003;66(1):25-33.
2003: Mei-Hwan Wu; Chun-Jung Lin; Chi-Long Chen; Ming-Jai Su; Selma Siu-Man Sun; Ann-Lii Cheng
Direct cardiac effects of As2O3 in rabbits: evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration.
Toxicology and applied pharmacology 2003;189(3):214-20.
2003: Ann-Lii Cheng; Chao A Hsiung; Ih-Jen Su; Pei-Jer Chen; Ming-Chih Chang; Chao-Jung Tsao; Woei-Yau Kao; Wu-Ching Uen; Chih-Hung Hsu; Hwei-Fang Tien; Tsu-Yi Chao; Li-Tzong Chen; Jacqueline Whang-Peng
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Hepatology (Baltimore, Md.) 2003;37(6):1320-8.
2003: Chiun Hsu; Chiung-Nien Chen; Li-Tzong Chen; Chen-Yao Wu; Pei-Ming Yang; Ming-Yang Lai; Po-Huang Lee; Ann-Lii Cheng
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
Oncology 2003;65(3):242-9.
2002: Chiun Hsu; Chiun-Sheng Huang; Tsu-Yi Chao; Yen-Shen Lu; Ching-Fang Bu; Mary M Chen; King-Jen Chang; Ann-Lii Cheng
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Cancer 2002;95(10):2044-50.
2002: Chih-Hung Hsu; Manfred Hergenhahn; Shuang-En Chuang; Pei-Yen Yeh; Ta-Chung Wu; Ming Gao; Ann-Lii Cheng
Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Anticancer research 2002;22(6C):4065-71.
2002: Chih-Hung Hsu; Ann-Lii Cheng; Chiun Hsu; Chih-Hsin Yang; Yen-Shen Lu; Chia-Chi Lin; Ching-Fang Bu; Kun-Huei Yeh
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Anticancer research 2002;22(6B):3621-7.
2002: Sow-Hsong Kuo; Liang-In Lin; Chee-Jen Chang; Yun-Ru Liu; Kuo-Sin Lin; Ann-Lii Cheng
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy.
Journal of clinical microbiology 2002;40(11):3909-12.
2002: Jin-Tung Liang; Kuo-Chin Huang; Hong-Shiee Lai; Po-Huang Lee; Yung-Ming Cheng; Hey-Chi Hsu; Ann-Lii Cheng; Chih-Hung Hsu; Kun-Huei Yeh; Shih-Ming Wang; Chi Tang; King-Jen Chang
High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection.
International journal of cancer. Journal international du cancer 2002;101(6):519-25.
2002: Chin-Lun Huang; Zhong-Zhe Lin; Ih-Jen Su; Tsu-Yi Chao; Hwei-Fang Tien; Ming-Chih Chang; Ming-Che Huang; Woei-Yau Kao; Jih-Luh Tang; Kun-Heui Yeh; Chiu-Hwa Wang; Chih-Hung Hsu; Mei-Yin Liu; Ann-Lii Cheng
Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma.
Leukemia & lymphoma 2002;43(7):1415-20.
2002: Shuang-En Chuang; Pei-Yen Yeh; Yen-Shen Lu; Gi-Ming Lai; Chao Ming Liao; Ming Gao; Ann-Lii Cheng
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.
Biochemical pharmacology 2002;63(9):1709-16.
2002: Pei-Yen Yeh; Shuang-En Chuang; Kun-Huei Yeh; Ying Chyi Song; Chee-Kwee Ea; Ann-Lii Cheng
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation.
Biochemical pharmacology 2002;63(8):1423-30.
2002: Manfred Hergenhahn; Ubaldo Soto; Annette Weninger; Axel Polack; Chih-Hung Hsu; Ann-Lii Cheng; Frank Rösl
The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Molecular carcinogenesis 2002;33(3):137-45.
2002: Chih-Hung Hsu; Shuang-En Chuang; Manfred Hergenhahn; Min-Liang Kuo; Jen-Kun Lin; Chang-Yao Hsieh; Ann-Lii Cheng
Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan.
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29 Suppl 1():194-200.
2002: Jin-Tung Liang; Kuo-Chin Huang; Yung-Ming Cheng; Hey-Chi Hsu; Ann-Lii Cheng; Chih-Hung Hsu; Kun-Huei Yeh; Shih-Ming Wang; King-Jen Chang
P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.
International journal of cancer. Journal international du cancer 2002;97(4):451-7.
2002: Chang-Hao Yang; C M Tsai; L S Wang; Yung-Chie Lee; C J Chang; L T Lui; Sang-Hue Yen; Chiun Hsu; Ann-Lii Cheng; M Y Liu; S C Chiang; Y M Chen; K T Luh; M H Huang; P-C Yang; Reury-Perng Perng
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.
British journal of cancer 2002;86(2):190-5.
2002: Chiun Hsu; Chin-Lun Huang; Hey-Chi Hsu; Po-Huang Lee; Shiou-Jeng Wang; Ann-Lii Cheng
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity.
Cancer 2002;94(2):415-20.
2002: Chih-Hung Hsu; Chi-Long Chen; Ruey-Long Hong; Kai-Lii Chen; Jing-Fang Lin; Ann-Lii Cheng
Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
Oncology 2002;62(4):305-12.
2001: Ann-Lii Cheng; Chih-Hung Hsu; Jen-Kun Lin; Mow-Ming Hsu; Yunn-Fang Ho; T S Shen; J Y Ko; Jaw-Town Lin; Bor-Ru Lin; W Ming-Shiang; Hsin-Su Yu; Shiou-Hwa Jee; G S Chen; T M Chen; Chi-An Chen; Ming-Kuen Lai; Yeong-Shiau Pu; MH Pan; Ying-Jan Wang; C C Tsai; Chang-Yao Hsieh
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
Anticancer research 2001;21(4B):2895-900.
2001: Pei-Yen Yeh; Shuang-En Chuang; Kun-Huei Yeh; Ying Chyi Song; Ann-Lii Cheng
Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin.
Biochemical and biophysical research communications 2001;284(4):880-6.
2001: Chun-Ching Lin; Chih-Hung Hsu; Jun Chen; T C Tsai; Ann-Lii Cheng; Yeong-Shiau Pu
A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer.
Anticancer research 2001;21(2B):1385-90.
2001: Chih-Hung Hsu; Jun Chen; Chen-Yao Wu; Ann-Lii Cheng; Yeong-Shiau Pu
Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
Anticancer research 2001;21(1B):711-5.
2001: Chiun Hsu; Chi-Ling Chen; Li-Tzong Chen; H T Liu; Yee-Chun Chen; C M Jan; C S Liu; Ann-Lii Cheng
Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: does histologic evidence of MALT affect chemotherapy response?
Cancer 2001;91(1):49-56.
2000: K C Wang; Ann-Lii Cheng; Shuang-En Chuang; H C Hsu; Ih-Jen Su
Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions.
Experimental hematology 2000;28(12):1441-50.
2000: Kun-Huei Yeh; S H Yeh; Chih-Hung Hsu; T M Wang; I F Ma; Ann-Lii Cheng
Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil.
British journal of cancer 2000;83(11):1510-5.
2000: Shuang-En Chuang; Ann-Lii Cheng; J K Lin; M L Kuo
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2000;38(11):991-5.
2000: Wei-Liang Shih; Min-Liang Kuo; Shuang-En Chuang; Ann-Lii Cheng; Shin-Lian Doong
Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway.
The Journal of biological chemistry 2000;275(33):25858-64.
2000: H T Liu; Chiun Hsu; Chi-Ling Chen; IP Chiang; Li-Tzong Chen; Yee-Chun Chen; Ann-Lii Cheng
Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach.
American journal of hematology 2000;64(3):175-9.
2000: S H Kuo; C L Chen; Chiun-Sheng Huang; Ann-Lii Cheng
Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
Anticancer research 2000;20(3B):2219-22.
2000: Chih-Hung Hsu; Mao-Yuan Chen; Ann-Lii Cheng
Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
Anticancer research 2000;20(2B):1159-61.
2000: Shuang-En Chuang; M L Kuo; C H Hsu; C R Chen; J K Lin; Gi-Ming Lai; C Y Hsieh; Ann-Lii Cheng
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.
Carcinogenesis 2000;21(2):331-5.
1999: Yung-Hsin Chin; Jacqueline Ming Liu; John Jen Tai; M S Chuang; Y L Ho; Y M Chen; Jacqueline Whang-Peng; Ann-Lii Cheng
The significance of body weight change in non-Hodgkins lymphoma.
Anticancer research 1999;19(6C):5607-10.
1999: Chih-Hung Hsu; Kun-Huei Yeh; L T Lui; Y C Lee; Ching-Fang Bu; H P Wang; Jaw-Town Lin; Ann-Lii Cheng
Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
Anticancer research 1999;19(5C):4463-7.
1999: Chih-Hsin Yang; Ann-Lii Cheng; Kun-Huei Yeh; Chong-Jen Yu; J F Lin; Pan-Chyr Yang
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.
Cancer 1999;86(3):415-20.
1999: Kun-Huei Yeh; Huang-Chun Lien; Su-Ming Hsu; Ann-Lii Cheng
Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma.
American journal of hematology 1999;60(2):161-3.
1999: Jin-Tung Liang; K J Chang; J C Chen; C C Lee; Y M Cheng; H C Hsu; Ming-Shiang Wu; S M Wang; Jaw-Town Lin; Ann-Lii Cheng
Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
Oncology 1999;57(2):149-56.
1998: Shin-Lian Doong; M H Lin; M M Tsai; T R Li; Shuang-En Chuang; Ann-Lii Cheng
Transactivation of the human MDR1 gene by hepatitis B virus X gene product.
Journal of hepatology 1998;29(6):872-8.
1998: Ann-Lii Cheng; Kun-Huei Yeh; R L Fine; Shuang-En Chuang; Chih-Hsin Yang; L H Wang; Ding-Shinn Chen
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
Hepato-gastroenterology 1998;45(24):1955-60.
1998: Min-Liang Kuo; Shing-Chuan Shen; Chang-Hao Yang; Shuang-En Chuang; Ann-Lii Cheng; Tien-Shang Huang
Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Oncogene 1998;17(17):2225-34.
1998: Yeong-Shiau Pu; Ann-Lii Cheng; Jun Chen; Jing-Yi Guan; Shiu-Hui Lu; M K Lai; Chang-Yao Hsieh
Megestrol acetate antagonizes cisplatin cytotoxicity.
Anti-cancer drugs 1998;9(8):733-8.
1998: Kun-Huei Yeh; Ming-Tsan Lin; Dong-Tsamn Lin; J L Tang; LT Lui; J F Lin; Y S Chang; Ann-Lii Cheng; S C Yu; King-Jen Chang; Y C Chen
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers.
Breast cancer research and treatment 1998;49(3):237-44.
1998: K H Yeh; C L Chen; Chia-Tung Shun; Jaw-Town Lin; Wei-Jei Lee; Po-Huang Lee; Y C Chen; Ann-Lii Cheng
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers.
Journal of clinical gastroenterology 1998;26(4):274-8.
1998: Ann-Lii Cheng; Kun-Huei Yeh; Wu-Ching Uen; R L Hung; M Y Liu; Chiu-Hwa Wang
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
Cancer 1998;82(10):1946-51.
1998: Kun-Huei Yeh; Chia-Tung Shun; Chi-Ling Chen; Jaw-Town Lin; W J Lee; Po-Huang Lee; Yee-Chun Chen; Ann-Lii Cheng
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.
Cancer 1998;82(9):1626-31.
1998: Kun-Huei Yeh; Yee-Chun Chen; S H Yeh; C P Chen; Jaw-Town Lin; Ann-Lii Cheng
Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)--possible clinical significance in advanced gastric cancer.
Anticancer research 1998;18(2B):1283-6.
1998: Ann-Lii Cheng; Kun-Huei Yeh; Jaw-Town Lin; Chiun Hsu; M Y Liu
Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Anticancer research 1998;18(2B):1267-72.
1998: Kun-Huei Yeh; Ann-Lii Cheng
Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin.
British journal of haematology 1998;100(4):769-72.
1998: Ann-Lii Cheng; Shuang-En Chuang; R L Fine; Kun-Huei Yeh; C M Liao; Jong-Ding Lay; Ding-Shinn Chen
Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen.
Biochemical pharmacology 1998;55(4):523-31.
1997: M L Kuo; C W Chen; S H Jee; Shuang-En Chuang; Ann-Lii Cheng
Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells.
The Biochemical journal 1997;327 ( Pt 3)():663-7.
1997: Shuang-En Chuang; Shin-Lian Doong; M T Lin; Ann-Lii Cheng
Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene.
Biochemical and biophysical research communications 1997;238(2):482-6.
1997: Kun-Huei Yeh; Ann-Lii Cheng; MT Lin; Ruey-Long Hong; Chih-Hung Hsu; Jing-Fang Lin; King-Jen Chang; Po-Huang Lee; Yee-Chun Chen
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Anticancer research 1997;17(5B):3867-71.
1997: Yuan-Yi Chou; Ann-Lii Cheng; H C Hsu
Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation.
Journal of gastroenterology and hepatology 1997;12(8):569-75.
1997: Ying-Jan Wang; MH Pan; Ann-Lii Cheng; Liang-In Lin; Y S Ho; Chang-Yao Hsieh; Jen-Kun Lin
Stability of curcumin in buffer solutions and characterization of its degradation products.
Journal of pharmaceutical and biomedical analysis 1997;15(12):1867-76.
1997: Ann-Lii Cheng; Shuang-En Chuang; Ih-Jen Su
Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas.
Journal of the Formosan Medical Association = Taiwan yi zhi 1997;96(7):525-34.
1997: W S Hwang; C A Hsiung; W S Ko; C C Wang; J Y Chang; G M Lai; R K Hsieh; Chao-Jung Tsao; Li-Tzong Chen; C K Law; Ann-Lii Cheng; S F Fan; Cheng-Hwai Tzeng; T J Chiou; Jacqueline Whang-Peng
Weekly CAF chemotherapy for advanced breast cancer patients.
Oncology 1997;54(4):293-7.
1997: Chih-Hung Hsu; Kun-Huei Yeh; Li-Tzong Chen; J M Liu; C M Jan; Jaw-Town Lin; Yee-Chun Chen; Ann-Lii Cheng
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition.
Oncology 1997;54(4):275-80.
1997: Kun-Huei Yeh; Ann-Lii Cheng; Ih-Jen Su; MT Lin; Hwei-Fang Tien; M C Shen; C H Wang; Yee-Chun Chen
Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
Anticancer research 1997;17(3C):2269-72.
1997: Hui-Ju Ch'ang; Ih-Jen Su; Chi-Ling Chen; IP Chiang; Yee-Chun Chen; Chiu-Hwa Wang; Ann-Lii Cheng
Angioimmunoblastic lymphadenopathy with dysproteinemia--lack of a prognostic value of clear cell morphology.
Oncology 1997;54(3):193-8.
1997: Kun-Huei Yeh; Ann-Lii Cheng
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung.
Anticancer research 1997;17(2B):1341-3.
1997: Chih-Hung Hsu; Kun-Huei Yeh; Ann-Lii Cheng
Thymic carcinoma with autoimmune syndrome: successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin.
Anticancer research 1997;17(2B):1331-4.
1997: Chiun Hsu; Kun-Huei Yeh; Ruey-Long Hong; Chang-Hao Yang; Ming-Tsan Lin; Yee-Chun Chen; Ann-Lii Cheng
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
Journal of the Formosan Medical Association = Taiwan yi zhi 1997;96(3):185-8.
1996: IP Chiang; HH Wang; Ann-Lii Cheng; Jaw-Town Lin; Ih-Jen Su
Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: clinicopathologic analysis of 19 cases.
Journal of the Formosan Medical Association = Taiwan yi zhi 1996;95(11):857-65.
1996: W C Chou; Ih-Jen Su; Hwei-Fang Tien; D C Liang; Chiu-Hwa Wang; Y C Chang; Ann-Lii Cheng
Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid.
Cancer 1996;78(8):1805-12.
1996: Y S Pu; T C Tsai; Ann-Lii Cheng; C Y Tsai; N F Tseng; I J Su; C Y Hsieh; Ming-Kuen Lai
Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.
The Journal of urology 1996;156(1):271-5.
1996: Ann-Lii Cheng; Yee-Chun Chen; Kun-Huei Yeh; Shuang-En Chuang; B R Chen; Ding-Shinn Chen
Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma.
Cancer 1996;77(5):872-7.
1996: Y S Pu; T S Hsieh; Ann-Lii Cheng; N F Tseng; I J Su; C Y Hsieh; Ming-Kuen Lai; T C Tsai
Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
British journal of urology 1996;77(1):76-85.
1995: Ih-Jen Su; Chiu-Hwa Wang; Ann-Lii Cheng; Rong-Long Chen
Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
Leukemia & lymphoma 1995;19(5-6):401-6.
1995: Kun-Huei Yeh; Ann-Lii Cheng; Hwei-Fang Tien
Primary T cell leptomeningeal lymphoma--successful treatment with systemic chemotherapy.
Oncology 1995;52(6):501-4.
1995: Wei-Jei Lee; Jaw-Town Lin; W C Lee; Chia-Tung Shun; Ruey-Long Hong; Ann-Lii Cheng; Po-Huang Lee; T C Wei; K M Chen
Clinicopathologic characteristics of Helicobacter pyloric seropositive gastric adenocarcinomas.
Journal of clinical gastroenterology 1995;21(3):203-7.
1995: Y S Pu; T S Hsieh; T C Tsai; Ann-Lii Cheng; C Y Hsieh; I J Su; Ming-Kuen Lai
Tamoxifen enhances the chemosensitivity of bladder carcinoma cells.
The Journal of urology 1995;154(2 Pt 1):601-5.
1995: Shuang-En Chuang; K C Wang; Ann-Lii Cheng
Single-step direct cloning of PCR products.
Trends in genetics : TIG 1995;11(1):7-8.
1994: Kun-Huei Yeh; Ann-Lii Cheng
Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid.
Journal of the Formosan Medical Association = Taiwan yi zhi 1994;93(8):721-3.
1994: M Yao; Ann-Lii Cheng; Ih-Jen Su; M T Lin; W C Uen; Hwei-Fang Tien; Chiu-Hwa Wang; Yee-Chun Chen
Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma.
British journal of haematology 1994;87(3):535-43.
1994: Ann-Lii Cheng; Ih-Jen Su; C C Chen; Hwei-Fang Tien; J D Lay; B R Chen; Y S Pu; Ruey-Long Hong; Ming-Ching Shen; Chiu-Hwa Wang
Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1185-92.
1994: Ann-Lii Cheng; Ih-Jen Su; Hwei-Fang Tien; C C Wang; Yee-Chun Chen; Chiu-Hwa Wang
Characteristic clinicopathologic features of adult B-cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin.
Cancer 1994;73(3):706-10.
1994: Kun-Huei Yeh; Ann-Lii Cheng; Yee-Chun Chen; B R Chen; Wei-Jei Lee; Jaw-Town Lin; Po-Huang Lee; King-Jen Chang; Chiu-Hwa Wang; Teh-Hong Wang
Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.
Journal of the Formosan Medical Association = Taiwan yi zhi 1994;93(1):20-4.
1993: Ih-Jen Su; Ann-Lii Cheng; Tsen-Fang Tsai; J D Lay
Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes.
British journal of haematology 1993;85(4):826-8.
1993: Ih-Jen Su; Tsen-Fang Tsai; Ann-Lii Cheng; C C Chen
Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
Journal of the American Academy of Dermatology 1993;29(5 Pt 1):685-92.
1993: Ih-Jen Su; Y H Hsu; M T Lin; Ann-Lii Cheng; Chiu-Hwa Wang; L M Weiss
Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis.
Cancer 1993;72(6):2019-27.
1993: Ann-Lii Cheng; Ih-Jen Su; Yee-Chun Chen; W C Uen; Chiu-Hwa Wang
Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma.
Cancer 1993;72(3):909-16.
1993: Ann-Lii Cheng; Ih-Jen Su; Yee-Chun Chen; T C Lee; Chiu-Hwa Wang
Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):109-15.
1992: Tsen-Fang Tsai; Ih-Jen Su; Y C Lu; Ann-Lii Cheng; H P Yeh; H C Hsieh; H F Tien; J S Chen; W C Uen
Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus.
Journal of the American Academy of Dermatology 1992;26(1):31-8.
1991: EO Ngo; T P Sun; J Y Chang; C C Wang; K H Chi; Ann-Lii Cheng; LM Nutter
Menadione-induced DNA damage in a human tumor cell line.
Biochemical pharmacology 1991;42(10):1961-8.
1991: J M Chow; Ann-Lii Cheng; Ih-Jen Su; Chiu-Hwa Wang
13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma.
Cancer 1991;67(10):2490-4.
1991: LM Nutter; Ann-Lii Cheng; H L Hung; R K Hsieh; EO Ngo; T W Liu
Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines.
Biochemical pharmacology 1991;41(9):1283-92.
1991: Ih-Jen Su; H C Hsieh; K H Lin; W C Uen; C L Kao; Chien-Jen Chen; Ann-Lii Cheng; M E Kadin; Jen-Yang Chen
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis.
Blood 1991;77(4):799-808.
1991: Ih-Jen Su; I C Chang; Ann-Lii Cheng
Expression of growth-related genes and drug-resistance genes in HTLV-I-positive and HTLV-I-negative post-thymic T-cell malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():151-5.
1990: Ih-Jen Su; Y C Wu; Y C Chen; H C Hsieh; Ann-Lii Cheng; Chiu-Hwa Wang; M E Kadin
Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes.
Journal of the American Academy of Dermatology 1990;23(4 Pt 1):653-62.
1989: Ann-Lii Cheng; Yee-Chun Chen; Chiu-Hwa Wang; Ih-Jen Su; H C Hsieh; J Y Chang; W S Hwang; W C Su; T W Liu; Hwei-Fang Tien
Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(6):725-31.